Essential oil from leaves of Cinnamomum osmophloeum acts as a xanthine oxidase inhibitor and reduces the serum uric acid levels in oxonate-induced mice-Reference-Cited by-同舟云学术

Essential oil from leaves of Cinnamomum osmophloeum acts as a xanthine oxidase inhibitor and reduces the serum uric acid levels in oxonate-induced mice

Published:2008-11 Issue:11 Volume:15 Page:940-945
ISSN:0944-7113
Container-title:Phytomedicine
language:en
Short-container-title:Phytomedicine

Author:

Wang S.Y.,Yang C.W.,Liao J.W.,Zhen W.W.,Chu F.H.,Chang S.T.

Publisher

Elsevier BV

Subject

Complementary and alternative medicine,Drug Discovery,Pharmaceutical Science,Pharmacology,Molecular Medicine

Reference22 articles.

1. A simplified alkaline phosphotungstate assay for uric acid in serum;Carroll;Clin. Chem.,1971

2. Study on the anti-inflammatory activity of essential oil from leaves of Cinnamomum osmophloeum;Chao;J. Agric. Food Chem.,2005

3. Antimite activity of essential oils and their components from Cinnamomum osmophloeum;Chen;Q. J. Chin. For.,2002

4. Antitermitic activity of leaf essential oils and components from Cinnamomum osmophloeum;Chang;J. Agric. Food Chem.,2002

5. Antibacterial activity of leaf essential oils and their constituents from Cinnamomum osmophloeum;Chang;J. Ethnopharmacol.,2001

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Review of Medicinal Plants and Phytochemicals for the Management of Gout;Current Rheumatology Reviews;2024-07

2. Cinnamaldehyde inhibits the NLRP3 inflammasome by preserving mitochondrial integrity and augmenting autophagy in Shigella sonnei-infected macrophages;Journal of Inflammation;2024-06-05

3. Composition Characterization of Cinnamomum osmophloeum Kanehira Hydrosol and Its Enhanced Effects on Erectile Function;Plants;2024-05-31

4. Herbal remedies in the management of hyperuricemia and gout: A review of in vitro, in vivo and clinical evidences;Phytotherapy Research;2024-04-24

5. Inhibition of Xanthine Oxidase by 4-nitrocinnamic Acid: In Vitro and In Vivo Investigations and Docking Simulations;Current Pharmaceutical Biotechnology;2024-03